Literature DB >> 27746069

Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.

Jacob Taylor1, William S Anderson2, Jason Brandt3, Zoltan Mari4, Gregory M Pontone5.   

Abstract

Although Parkinson disease (PD) is defined clinically by its motor symptoms, it is increasingly recognized that much of the disability and worsened quality of life experienced by patients with PD is attributable to psychiatric symptoms. The authors describe a model of multidisciplinary care that enables these symptoms to be effectively managed. They describe neuropsychiatric complications of PD itself and pharmacologic and neurostimulation treatments for parkinsonian motor symptoms and discuss the management of these complications. Specifically, they describe the clinical associations between motor fluctuations and anxiety and depressive symptoms, the compulsive overuse of dopaminergic medications prescribed for motor symptoms (the dopamine dysregulation syndrome), and neuropsychiatric complications of these medications, including impulse control disorders, psychosis, and manic syndromes. Optimal management of these problems requires close collaboration across disciplines because of the potential for interactions among the pathophysiologic process of PD, motor symptoms, dopaminergic drugs, and psychiatric symptoms. The authors emphasize how their model of multidisciplinary care facilitates close collaboration among psychiatrists, other mental health professionals, neurologists, and functional neurosurgeons and how this facilitates effective care for patients who develop the specific neuropsychiatric complications discussed. Copyright Â
© 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anxiety; depression; dopamine replacement therapy (DRT); multidisciplinary care; neuropsychiatric (symptoms), nonmotor (symptoms); parkinson disease

Mesh:

Substances:

Year:  2016        PMID: 27746069      PMCID: PMC5136297          DOI: 10.1016/j.jagp.2016.08.017

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  48 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

Review 2.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Authors:  Susan H Fox; Regina Katzenschlager; Shen-Yang Lim; Bernard Ravina; Klaus Seppi; Miguel Coelho; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

Review 3.  Treatment of motor and non-motor features of Parkinson's disease with deep brain stimulation.

Authors:  Alfonso Fasano; Antonio Daniele; Alberto Albanese
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

Review 4.  Understanding disability in Parkinson's disease.

Authors:  Lisa M Shulman
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

Review 5.  Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework.

Authors:  D Okai; M Samuel; S Askey-Jones; A S David; R G Brown
Journal:  Eur J Neurol       Date:  2011-05-25       Impact factor: 6.089

6.  Prevalence of psychotic symptoms in a community-based Parkinson disease sample.

Authors:  Joel Mack; Peter Rabins; Karen Anderson; Susanne Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Justin Palanci; Gregory Pontone; Howard Weiss; James R Williams; Laura Marsh
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

7.  Impaired decision-making in Parkinson's disease.

Authors:  Masaru Mimura; Reiko Oeda; Mitsuru Kawamura
Journal:  Parkinsonism Relat Disord       Date:  2006-03-23       Impact factor: 4.891

8.  Anxiety in Parkinson's disease: Symptom dimensions and overlap with depression and autonomic failure.

Authors:  Sonja Rutten; Ires Ghielen; Chris Vriend; Adriaan W Hoogendoorn; Henk W Berendse; Albert F G Leentjens; Ysbrand D van der Werf; Jan H Smit; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2014-12-10       Impact factor: 4.891

9.  Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.

Authors:  Kelvin L Chou; Susan Messing; David Oakes; Peter D Feldman; Alan Breier; Joseph H Friedman
Journal:  Clin Neuropharmacol       Date:  2005 Sep-Oct       Impact factor: 1.592

10.  Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers.

Authors:  David Okai; Sally Askey-Jones; Michael Samuel; Sean S O'Sullivan; K Ray Chaudhuri; Anne Martin; Joel Mack; Richard G Brown; Anthony S David
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

View more
  6 in total

1.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

2.  Implementation and evaluation of Parkinson disease management in an outpatient clinical pharmacist-run neurology telephone clinic.

Authors:  Teodora Cristina Stefan; Nicole Elharar; Guadalupe Garcia
Journal:  Ment Health Clin       Date:  2018-04-26

Review 3.  Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson's disease.

Authors:  Gregory M Pontone; Nadeeka Dissanayka; Liana Apostolova; Richard G Brown; Roseanne Dobkin; Kathy Dujardin; Joseph H Friedman; Albert F G Leentjens; Eric J Lenze; Laura Marsh; Lynda Mari; Oury Monchi; Irene H Richard; Anette Schrag; Antonio P Strafella; Beth Vernaleo; Daniel Weintraub; Zoltan Mari
Journal:  NPJ Parkinsons Dis       Date:  2019-12-11

4.  COVID-19 Pandemic and Psychiatric Symptoms: The Impact on Parkinson's Disease in the Elderly.

Authors:  Delfina Janiri; Martina Petracca; Lorenzo Moccia; Luca Tricoli; Carla Piano; Francesco Bove; Isabella Imbimbo; Alessio Simonetti; Marco Di Nicola; Gabriele Sani; Paolo Calabresi; Anna Rita Bentivoglio
Journal:  Front Psychiatry       Date:  2020-11-27       Impact factor: 4.157

Review 5.  Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.

Authors:  Raquel N Taddei; Seyda Cankaya; Sandeep Dhaliwal; K Ray Chaudhuri
Journal:  Parkinsons Dis       Date:  2017-09-12

Review 6.  Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses.

Authors:  Marlena van Munster; Johanne Stümpel; Franziska Thieken; David J Pedrosa; Angelo Antonini; Diane Côté; Margherita Fabbri; Joaquim J Ferreira; Evžen Růžička; David Grimes; Tiago A Mestre
Journal:  J Pers Med       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.